Briët E - Search Results

1

A method to determine the optimal intensity of oral anticoagulant therapy.

Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. Rosendaal FR, et al. Among authors: briet e. Thromb Haemost. 1993 Mar 1;69(3):236-9. Thromb Haemost. 1993. PMID: 8470047

2

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

Cannegieter SC, Rosendaal FR, Wintzen AR, van der Meer FJ, Vandenbroucke JP, Briët E. Cannegieter SC, et al. Among authors: briet e. N Engl J Med. 1995 Jul 6;333(1):11-7. doi: 10.1056/NEJM199507063330103. N Engl J Med. 1995. PMID: 7776988 Free article.

3

Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients.

Azar AJ, Deckers JW, Rosendaal FR, van Bergen PF, van der Meer FJ, Jonker JJ, Briët E. Azar AJ, et al. Among authors: briet e. Thromb Haemost. 1994 Sep;72(3):347-51. Thromb Haemost. 1994. PMID: 7855782 Clinical Trial.

4

Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS).

Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briët E, Vandenbroucke JP. Koster T, et al. Among authors: briet e. Thromb Haemost. 1994 Jun;71(6):719-22. Thromb Haemost. 1994. PMID: 7974338

5

Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.

Cannegieter SC, Rosendaal FR, Briët E. Cannegieter SC, et al. Among authors: briet e. Circulation. 1994 Feb;89(2):635-41. doi: 10.1161/01.cir.89.2.635. Circulation. 1994. PMID: 8313552 Free article. Review.

6

Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briët E. van der Meer FJ, et al. Among authors: briet e. Arch Intern Med. 1993 Jul 12;153(13):1557-62. doi: 10.1001/archinte.153.13.1557. Arch Intern Med. 1993. PMID: 8323419 Free article.

7

Optimal intensity of oral anticoagulant therapy after myocardial infarction.

Azar AJ, Cannegieter SC, Deckers JW, Briët E, van Bergen PF, Jonker JJ, Rosendaal FR. Azar AJ, et al. Among authors: briet e. J Am Coll Cardiol. 1996 May;27(6):1349-55. doi: 10.1016/0735-1097(96)00020-4. J Am Coll Cardiol. 1996. PMID: 8626943 Free article.

8

Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants.

van der Meer FJ, Rosendaal FR, Vandenbroucke JP, Briët E. van der Meer FJ, et al. Among authors: briet e. Thromb Haemost. 1996 Jul;76(1):12-6. Thromb Haemost. 1996. PMID: 8819244

9

High intensity of oral anticoagulant therapy in patients with cerebral haemorrhage: cause or consequence of the bleeding?

Cannegieter SC, Rosendaal FR, Bollen EL, Briët E. Cannegieter SC, et al. Among authors: briet e. Br J Haematol. 1997 Mar;96(3):497-9. doi: 10.1046/j.1365-2141.1997.d01-2051.x. Br J Haematol. 1997. PMID: 9054655 Free article.

10

The Leiden Thrombophilia Study (LETS).

van der Meer FJ, Koster T, Vandenbroucke JP, Briët E, Rosendaal FR. van der Meer FJ, et al. Among authors: briet e. Thromb Haemost. 1997 Jul;78(1):631-5. Thromb Haemost. 1997. PMID: 9198229 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters